Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study

Author： Alba Emilio   Ruiz-Borrego Manuel   Margelí Mireia   Rodríguez-Lescure Álvaro   Sánchez-Rovira Pedro   Ruiz Amparo   Mel-Lorenzo Jose   Ramos-Vázquez Manuel   Ribelles Nuria   Calvo Elisa   Casado Antonio   Márquez Antonia   Vicente David   García-Sáenz José   Martín Miguel  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.1, 2010-07, pp. : 169-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of pegylated liposomal doxorubicin (Caelyx&unknown;) as induction chemotherapy for patients with squamous cell cancer of the head and neck

By Harrington K.J.   Lewanski C.   Northcote A.D.   Whittaker J.   Peters A.M.   Vile R.G.   Stewart J.S.W.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2015-2022

Elsevier

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study

By                                    

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2137-2142

Spandidos Publications

Access to resources Recommend Favorite

Trabectedin plus pegylated liposomal doxorubicin: the return of a treatment option for ovarian cancer

By Clare John  

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1-1

Future Medicine

Access to resources Recommend Favorite

Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 49-51

Informa Healthcare

Access to resources Recommend Favorite